Abstract
Chronic inflammatory diseases, like rheumatoid arthritis (RA) have been described to cause central nervous system (CNS) activation. Less is known about environmental factors that enable the CNS to suppress peripheral inflammation in RA. Here, we identified gut microbiota-derived histamine as such factor. We show that low levels of histamine activate the enteric nervous system, increase inhibitory neurotransmitter concentrations in the spinal cord and restore homeostatic microglia, thereby reducing inflammation in the joints. Selective histamine 3 receptor (H3R) signaling in the intestine is critical for this effect, as systemic and intrathecal application did not show effects. Microglia depletion or pharmacological silencing of local nerve fibers impaired oral H3R agonist-induced pro-resolving effects on arthritis. Moreover, therapeutic supplementation of the SCFA propionate identified one way to expand local intestinal histamine concentrations in mice and humans. Thus, we define a gut-CNS-joint axis pathway where microbiota-derived histamine initiates the resolution of arthritis via the CNS. Graphical Abstract Gut microbiota-derived histamine activates enteric neurons via H3R Local intestinal H3R activation induces shift to homeostatic microglia in the spinal cord CNS controlled decrease in endothelial leakiness resolves synovial inflammation
Full text
2,209 characters
· extracted from
oa-doi-fallback
· click to expand
Gut-specific H3R signaling orchestrates microglia-dependent resolution of peripheral inflammation
Abstract
Chronic inflammatory diseases, like rheumatoid arthritis (RA) have been described to cause central nervous system (CNS) activation. Less is known about environmental factors that enable the CNS to suppress peripheral inflammation in RA. Here, we identified gut microbiota-derived histamine as such factor. We show that low levels of histamine activate the enteric nervous system, increase inhibitory neurotransmitter concentrations in the spinal cord and restore homeostatic microglia, thereby reducing inflammation in the joints. Selective histamine 3 receptor (H3R) signaling in the intestine is critical for this effect, as systemic and intrathecal application did not show effects. Microglia depletion or pharmacological silencing of local nerve fibers impaired oral H3R agonist-induced pro-resolving effects on arthritis. Moreover, therapeutic supplementation of the SCFA propionate identified one way to expand local intestinal histamine concentrations in mice and humans. Thus, we define a gut-CNS-joint axis pathway where microbiota-derived histamine initiates the resolution of arthritis via the CNS.
Gut microbiota-derived histamine activates enteric neurons via H3R
Local intestinal H3R activation induces shift to homeostatic microglia in the spinal cord
CNS controlled decrease in endothelial leakiness resolves synovial inflammation
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
The authors have declared that no conflict of interest exists.
Subject Area
- Biochemistry (17728)
- Bioengineering (13916)
- Bioinformatics (42037)
- Biophysics (21489)
- Cancer Biology (18637)
- Cell Biology (25553)
- Clinical Trials (138)
- Developmental Biology (13401)
- Ecology (19941)
- Epidemiology (2067)
- Evolutionary Biology (24367)
- Genetics (15622)
- Genomics (22547)
- Immunology (17764)
- Microbiology (40475)
- Molecular Biology (17208)
- Neuroscience (88747)
- Paleontology (667)
- Pathology (2842)
- Pharmacology and Toxicology (4834)
- Physiology (7659)
- Plant Biology (15175)
- Synthetic Biology (4304)
- Systems Biology (9835)
- Zoology (2272)
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.